Hyperbaric Oxygen Therapy
Breathing pure oxygen in a pressurized chamber to enhance tissue oxygenation, promote healing, and stimulate stem cell mobilization.
Evidence Summary
Hyperbaric oxygen therapy (HBOT) has robust randomized-trial support across more than a dozen FDA-approved indications, and the evidence base for cognitive and cellular-aging applications has continued to strengthen through 2025–2026. A 2026 systematic review and meta-analysis of 35 randomized controlled trials (3,036 participants) found that adding HBOT to standard care for post-stroke cognitive impairment improved cognitive scores versus control — a pooled mean gain of +2.90 points on the MoCA (95% CI 2.47–3.33) and +2.68 points on the MMSE (95% CI 2.20–3.16) — though the authors graded the certainty of evidence as low, with high between-study heterogeneity and all included trials conducted in China (Hu et al., Frontiers in Neurology, 2026). A 2025 phase II double-blind, sham-controlled randomized trial in adults with persistent symptoms after brain injury (47 analyzed) reported a greater reduction in total neurobehavioral symptoms after 40 sessions at 1.5 ATA than sham (between-group difference 7.0 points, 95% CI 1.7–12.3, p=0.01), with blinding validated by chance-level allocation guesses (Weaver et al., Scientific Reports, 2025). These build on earlier work in healthy aging adults, where 60 daily sessions at 2 ATA were associated with increased leukocyte telomere length (up to ~38% in B cells) and roughly a one-third reduction in senescent T-helper cells (Hachmo et al., Aging, 2020), and with cognitive gains in attention and information-processing speed (net effect sizes 0.75–0.79; Hadanny et al., Aging, 2020). Overall these findings are promising but derive from small-to-moderate trials and, for longevity endpoints, remain early-stage; HBOT for cognition and healthy aging is investigational, is not a cure, and should be delivered only under qualified medical supervision after screening for contraindications.
Evidence Scale
Mechanism of Action
Increases dissolved oxygen in plasma by 10-15x, stimulating angiogenesis, reducing inflammation, mobilizing stem cells, and enhancing mitochondrial function through hypoxia-inducible factor (HIF) pathway modulation.
Who Is This For?
Non-healing wounds, post-radiation, TBI/concussion, anti-aging protocols. Baseline assessment recommended.
Protocol & Dosing
Dose
1.5-3.0 ATA pressure. Pure oxygen or enriched air depending on protocol.
Frequency
Daily to 3x/week
Duration
20-60 sessions typical
Protocol Summary
Sessions in pressurized chamber at 1.5-3.0 ATA for 60-90 minutes. Protocol varies by indication.
Latest Evidence
2025–2026: cognitive, cellular-aging & post-injury evidence
A 2026 systematic review and meta-analysis of 35 randomized controlled trials (3,036 participants) found that adding hyperbaric oxygen therapy to standard care for post-stroke cognitive impairment improved cognitive scores versus control — a pooled gain of +2.90 points on the MoCA and +2.68 on the MMSE — though the authors rated the certainty of evidence as low, with high heterogeneity and all trials conducted in China. A 2025 phase II double-blind, sham-controlled randomized trial in adults with persistent symptoms after brain injury found a greater reduction in total neurobehavioral symptoms after 40 sessions at 1.5 ATA than sham (between-group difference 7.0 points, 95% CI 1.7–12.3, p=0.01), with blinding confirmed. These build on an earlier prospective trial in healthy aging adults in which 60 sessions at 2 ATA were associated with longer immune-cell telomeres and fewer senescent T-cells.
These are small-to-moderate trials and, for longevity endpoints, largely early-stage. HBOT for cognition and healthy aging is investigational, is not a cure, and is delivered only under qualified medical supervision after screening for contraindications such as untreated pneumothorax. Educational information, not medical advice.
Prospective trial · n=30
Telomere length increase after HBOT
Source: Hachmo et al., Aging (Albany NY), 2020 — 30 healthy aging adults, 60 daily sessions at 2 ATA. Telomere length change from baseline measured after HBOT.
Latest Evidence · 2026 Meta-analysis
HBOT and cognitive scores: 2026 meta-analysis
Pooled mean improvement in cognitive scores when HBOT is added to standard care for post-stroke cognitive impairment, across 35 randomized trials (3,036 patients). Higher is better. GRADE certainty: low.
Source: Hu et al., Frontiers in Neurology, 2026 (meta-analysis of 35 RCTs).
Related on Peak Human
HBOT at Peak Human
Physician-supervised hyperbaric oxygen protocols.
HBOT: Benefits & Latest Research
A plain-language review of the current HBOT evidence.
HBOT, Brain & Longevity
How HBOT is being studied for the brain and aging.
Therapeutic Plasma Exchange
Another regenerative therapy in the database.
Stem Cell Therapy
HBOT mobilizes stem cells; explore the related therapy.
Longevity Research Insider
Weekly review of new longevity research.
Key references: HBOT for post-stroke cognitive impairment: systematic review & meta-analysis — Front. Neurol. (2026) · Double-blind sham-controlled RCT of HBOT after brain injury — Scientific Reports (2025) · HBOT increases telomere length & reduces immunosenescence — Aging (2020) · HBOT for Alzheimer's disease: systematic review & meta-analysis — Front. Aging Neurosci. (2024) · Long-term outcomes of HBOT in post-COVID condition (RCT follow-up) — Scientific Reports (2024)
Interactions & Precautions
Contraindications
- Untreated pneumothorax
- Active malignancy (relative)
- Claustrophobia
- Certain medications
Potential Risks
- •Barotrauma
- •Oxygen toxicity at high pressures
- •Fire hazard in chamber
Potential Side Effects
Practitioner Notes
Clinical annotations from Dr. Goel
Screen for contraindications. Soft chambers (1.3 ATA) offer milder alternative. Consider 40-session protocols for neurological applications.
Dr. Sanjeev Goel
Chief Medical Officer, Peak Human
Cost & Access
Cost Range
$$$
Accessibility
Availability varies by location
All interventions
Database index- Acarbose
- Anti-IL-11 Therapy
- Apolipoprotein Testing
- Berberine
- Biological Age Testing
- Branched-Chain Amino Acid (BCAA) Restriction
- Breathwork
- CDK4/6 Inhibitors as Senomorphics
- ClC-1 Inhibition for Age-Related Muscle Weakness
- Cold Exposure Therapy
- Comprehensive Blood Panel
- Continuous Glucose Monitor
- CoQ10 (Ubiquinol)
- Creatine
- Devices Interventions
- DHEA Supplementation
- Diagnostics Interventions
- Dulaglutide
- Emerging Interventions
- Exenatide
- Exosome Therapy
- Follistatin Gene Therapy
- Full-Body MRI
- Gene Therapy
- Genetic Testing
- GLP-1 Agonists
- Glycation Reversal Enzymes (AGE Breakers)
- Glycine
- Growth Hormone Therapy
- Heart Rate Variability Training
- Heat Exposure / Sauna
- High-Intensity Interval Training
- Hormone Replacement Therapy (Female)
- Hormones Interventions
- Intermittent Fasting
- IV Nutrient Therapy
- Ketogenic Diet
- Klotho (alpha-Klotho) Therapies
- Lifestyle Interventions
- Liraglutide
- Low-Dose Naltrexone
- Magnesium
- Meditation
- Metformin
- NAD+ IV Therapy
- Neurofeedback
- NLRP3 Inflammasome Inhibition
- NMN (Nicotinamide Mononucleotide)
- Omega-3 Fatty Acids
- Orforglipron
- Ozone Therapy
- Partial Reprogramming
- PEMF Therapy
- Peptide Therapy
- Pharma Interventions
- Plasma p-Tau217 Testing
- PRP Therapy
- RANKL Inhibition (Denosumab)
- Rapamycin
- Red Light Therapy
- Resistance Training
- Resveratrol
- Semaglutide
- Senolytics
- Senolytics (Fisetin)
- Sleep Optimization
- Stem Cell Therapy
- Supplements Interventions
- Survodutide
- Telomeric DNA Damage Response (tDDR) Inhibition
- Testosterone Replacement Therapy
- Therapeutic Plasma Exchange
- Therapies Interventions
- Thyroid Optimization
- Tirzepatide
- Vitamin D3
- Wearable Fitness Trackers
- Young Plasma Factors
- Zone 2 Cardio
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
